PubRank

Thomas M O'Dorisio

Author PubWeight™ 39.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. J Clin Oncol 2009 3.18
2 Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004 2.51
3 Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients. Pancreas 2008 2.24
4 NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 2010 1.90
5 Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study. Endocr Relat Cancer 2012 1.76
6 When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Ann Surg Oncol 2009 1.57
7 The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 2010 1.51
8 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol 2010 1.49
9 Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas 2005 1.27
10 Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency. Pancreas 2006 1.21
11 Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience. Pancreas 2014 1.01
12 Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 2002 0.97
13 The value of preoperative imaging in small bowel neuroendocrine tumors. Ann Surg Oncol 2013 0.91
14 Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution. Ann Surg Oncol 2011 0.91
15 Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 2007 0.89
16 Medical management of metastatic medullary thyroid cancer. Cancer 2014 0.88
17 Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling. Surgery 2012 0.87
18 Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors. Surgery 2013 0.87
19 A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy. Pancreas 2010 0.86
20 Neuroendocrine tumors arising in Meckel's diverticula: frequency of advanced disease warrants aggressive management. J Gastrointest Surg 2013 0.85
21 Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006. Pediatr Blood Cancer 2011 0.84
22 Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors. Clin Exp Metastasis 2014 0.83
23 Validation of neurokinin a assays in the United States and Europe. Pancreas 2011 0.83
24 Pancreastatin predicts survival in neuroendocrine tumors. Ann Surg Oncol 2014 0.83
25 Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors. Pancreas 2013 0.83
26 A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon. Regul Pept 2003 0.80
27 A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs). Pancreas 2013 0.80
28 Neuroendocrine tumors: a critical appraisal of management strategies. Pancreas 2010 0.79
29 Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association? Pancreas 2014 0.79
30 Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators. Endocrinol Metab Clin North Am 2010 0.78
31 Age-dependent levels of plasma neuropeptides in normal children. Regul Pept 2002 0.77
32 Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs. Neurosci Lett 2009 0.76
33 Intracerebroventricular infusion of bombesin modulates GIP secretion in conscious dogs. Neuropharmacology 2009 0.76
34 Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution. Pancreas 2014 0.75
35 The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas 2017 0.75
36 Insular thyroid carcinoma in a patient with Cowden syndrome. Laryngoscope 2010 0.75
37 Two-career families: published data and personal reflections. Exp Biol Med (Maywood) 2003 0.75